HIGHLIGHTS
- who: Shui-Qing Bi from the Uppsala University, Sweden Research Centers (HZ), Germany have published the Article: Combined treatment with epigenetic agents enhances anti-tumor activity of MAGE-D4 peptide-specific T cells by upregulating the MAGE-D4 expression in glioma, in the Journal: (JOURNAL)
- what: The authors preliminarily explored the combination of epigenetic drugs and T_cell therapy for glioma treatment.
- how: Analysis of 49 gliomas and four normal brain tissues in the GSE2223 dataset showed that the expression of MAGE-D4 mRNA in glioma was significantly higher than that of normal brain . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.